Search results
Showing 256 to 270 of 557 results for women's health
Is obesity an independent risk factor for perinatal morbidity and mortality?
fetal heart rate, uterine contractions and fetal position in women who are obese. These women are likely to have more...
Adrenal insufficiency: identification and management (NG243)
This guideline covers identifying and managing adrenal insufficiency (hypoadrenalism) in babies, children, young people and adults. It aims to improve the treatment of primary, secondary and tertiary adrenal insufficiency, and the prevention and management of adrenal crisis.
Secukinumab for treating moderate to severe hidradenitis suppurativa (TA935)
Evidence-based recommendations on secukinumab (Cosentyx) for active moderate to severe hidradenitis suppurativa (acne inversa) in adults.
Find out more about NICE technology appraisals advisory committee D members
Recommendation ID NG3/6 Question In women with type 1 diabetes who are planning to become pregnant, what is the most effective method of
Recommendation ID NG3/7 Question In women with type 1 diabetes who are already pregnant, what is the most effective method of glucose...
CG192/1 Question What methods can improve the identification of women at high risk of postpartum psychosis and reduce this risk? Any...
Gastro-oesophageal reflux in children and young people (QS112)
This quality standard covers managing symptoms of reflux (regurgitation or bringing up feeds) in babies, children and young people (under 18). It also covers diagnosing and managing gastro-oesophageal reflux disease (also called GORD), which is more severe reflux and heartburn. It describes high-quality care in priority areas for improvement.
View quality statements for QS112Show all sections
Sections for QS112
- Quality statements
- Quality statement 1: Information about gastro-oesophageal reflux (GOR) in infants
- Quality statement 2: Breast-fed infants – feeding assessment
- Quality statement 3: Formula-fed infants – stepped-care approach
- Quality statement 4: Alginate therapy
- Quality statement 5: Symptoms that do not need investigation or treatment
- Quality statement 6: Acid-suppressing drugs
- Quality statement 7: Upper gastrointestinal (GI) contrast study
miscarriage: In women with confirmed miscarriage, does the type of management strategy (expectant, medical and surgical) impact on...
induction for women:- Is there an association between ovulation induction or ovarian stimulation and adverse long-term (over 20 years)...
Evidence-based recommendations on erenumab (Aimovig) for preventing migraine in adults.
in pregnancy and the postnatal period effective at improving outcomes for women and their babies? Any explanatory notes(if applicable)...
NICE has developed a medtech innovation briefing (MIB) on VIDAvision for lung volume analysis in emphysema .
NICE has developed a medtech innovation briefing (MIB) on TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation .
Early value assessment (EVA) guidance on CaRi-Heart for predicting cardiac risk in suspected coronary artery disease.